The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTMolecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignRobert E. Babine and Steven L. BenderView Author Information Agouron Pharmaceuticals, Inc., 3565 General Atomics Court, San Diego, California 92121-1122 Cite this: Chem. Rev. 1997, 97, 5, 1359–1472Publication Date (Web):August 5, 1997Publication History Received14 February 1997Revised19 May 1997Published online5 August 1997Published inissue 1 August 1997https://pubs.acs.org/doi/10.1021/cr960370zhttps://doi.org/10.1021/cr960370zresearch-articleACS PublicationsCopyright © 1997 American Chemical SocietyRequest reuse permissionsArticle Views7012Altmetric-Citations789LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Inhibitors,Ligands,Monomers,Noncovalent interactions,Peptides and proteins Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–250 of 250
Feng, S., Kapoor, T. M., Shirai, F., Combs, A. P., & Schreiber, S. L. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90134-9 · Cited by 58
Poliovirus thiol proteinase 3C can utilize a serine nucleophile within the putative catalytic triad.
Lawson, M. A., & Semler, B. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9919 · Cited by 57
Schultz, R. M., Varma-Nelson, P., Ortiz, R., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94215-8 · Cited by 56
Sampson, N. S., & Bartlett, P. A. (1991) · Biochemistry · doi:10.1021/bi00222a031 · Cited by 56
Armistead, D. M., Badia, M. C., Deininger, D. D., Duffy, J., Saunders, J. O., Tung, R. D., Thomson, J. A., DeCenzo, M. T., Futer, O., Livingston, D. J., et al. (1995) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994014502 · Cited by 56
Novel indolactam-based inhibitors of matrix metalloproteinases
Castelhano, A. L., Billedeau, R. J., Dewdney, N. J., Donnelly, S., Horne, S., Kurz, L. J., Liak, T. J., Martin, R. L., Uppington, R., Yuan, Z., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00233-j · Cited by 56
The Entropic Cost of Binding Water to Proteins
Bryan, W. P. (1994) · Science · doi:10.1126/science.7992059 · Cited by 53
Blundell, T. L., & Pearl, L. H. (1989) · Nature · doi:10.1038/337596a0 · Cited by 52
Conformational Analysis of the cis‐ and trans‐Isomers of FK506 by NMR and Molecular Dynamics
Mierke, D. F., Schmieder, P., Karuso, P., & Kessler, H. (1991) · Helvetica Chimica Acta · doi:10.1002/hlca.19910740513 · Cited by 52
Reich, S., Melnick, M., Davies, J. F., Appelt, K., Lewis, K. K., Fuhry, M. A. M., Pino, M. J., Trippe, A. J., Nguyen, D., & Dawson, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3298 · Cited by 50
Spaltenstein, A., Leban, J. J., Huang, J. J., Reinhardt, K. R., Viveros, O. H., Sigafoos, J., & Crouch, R. C. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)00018-4 · Cited by 49
Activation of an inactive immunophilin by mutagenesis
Rosen, M. K., Yang, D., Martin, P. K., & Schreiber, S. L. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00055a082 · Cited by 44
Reich, S., Melnick, M., Pino, M. J., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960093o · Cited by 43
Jhoti, H., Singh, O. M. P., Weir, M., et al. (1994) · Biochemistry · doi:10.1021/bi00194a005 · Cited by 43
Design, synthesis and X-ray crystallographic studies of novel FKBP-12 ligands
Babine, R. E., Bleckman, T. M., Kissinger, C. R., Showalter, R. E., Pelletier, L. A., Lewis, C. T., Tucker, K. D., Moomaw, E. W., Parge, H. E., & Villafranca, J. E. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00290-a · Cited by 42
Self-citationEdwards, P. D., Andisik, D. W., Strimpler, A. M., Gomes, B. C., & Tuthill, P. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950684z · Cited by 42
Crystal structures of two engineered thiol trypsins
McGrath, M. E., Wilke, M. E., Higaki, J. N., Craik, C. S., & Fletterick, R. J. (1989) · Biochemistry · doi:10.1021/bi00450a005 · Cited by 40
Wiederrecht, G., & Etzkorn, F. A. (1994) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171737 · Cited by 40
The medicinal chemistry of FK-506
Goulet, M. T., Rupprecht, K. M., Sinclair, P. J., Wyvratt, M. J., & Parsons, W. H. (1994) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171741 · Cited by 36
Zdanov, A. S., Wu, S., DiMaio, J., Konishi, Y., Li, Y., Wu, X., Edwards, B. F. P., Martin, P. D., & Cygler, M. (1993) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340170304 · Cited by 34
Wonacott, A. J., Cooke, R., Hayes, F. R. F., et al. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00073a010 · Cited by 33
Radhakrishnan, R., Presta, L. G., MEYER, E. F. J., et al. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90291-9 · Cited by 32
Synthesis and properties of peptidyl derivatives of arginylfluoromethanes
Angliker, H., Wikström, P., Rauber, P., et al. (1988) · Biochemical Journal · doi:10.1042/bj2560481 · Cited by 31
Melnick, M., Reich, S., Lewis, K. K., Mitchell, L. J., Nguyen, D., Trippe, A. J., Dawson, H., Davies, J. F., Appelt, K., Wu, B.-W., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960092w · Cited by 31
In vivo Inhibition of Cathepsin B by Peptidyl (Acyloxy)methyl Ketones
Wagner, B. M., Smith, R. A., Coles, P. J., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a012 · Cited by 30
The use of HIV-1 protease structure in inhibitor design
Babine, R. E., Zhang, N., Jürgens, A. R., Schow, S. R., Desai, P. R., James, J. C., & Semmelhack, M. F. (1992) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)81194-x · Cited by 30
Self-citationLee, M. H., & Bell, R. M. (1992) · Biochemistry · doi:10.1021/bi00137a013 · Cited by 29
Mattos, C., Giammona, D. A., Petsko, G. A., et al. (1995) · Biochemistry · doi:10.1021/bi00010a008 · Cited by 28
Bures, M. G., Hutchins, C. W., MAUS, M. L., Kohlbrenner, W. E., KADAM, S. K., & Erickson, J. W. (1990) · Tetrahedron Computer Methodology · doi:10.1016/0898-5529(90)90166-6 · Cited by 28
Conformation of FK506 in X-ray structures of its complexes with human recombinant FKBP12 mutants
Itoh, S., DeCenzo, M. T., Livingston, D. J., Pearlman, D. A., & Navia, M. A. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00337-s · Cited by 27
Cappalonga, A. M., Alexander, R., & Christianson, D. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41760-7 · Cited by 27
Structure-based drug design (SBDD): Every structure tells a story...
Reich, S., & Webber, S. E. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174536 · Cited by 26
Kreutter, K. D., Steinmetz, A. C. U., Liang, T. C., Prorok, M., Abeles, R. H., & Ringe, D. (1994) · Biochemistry · doi:10.1021/bi00250a033 · Cited by 25
Evidence for carbonate in the mantle
Berg, G. W. (1987) · Nature · doi:10.1038/327082a0 · Cited by 25
ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS
Kalish, V. J., Kaldor, S. W., Shetty, B. V., Tatlock, J. H., Davies, J. F., Hammond, M., Dressman, B. A., Fritz, J. S., Appelt, K., Reich, S., et al. (1995) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(23)00125-3 · Cited by 23
Clavulanate inactivation of Staphylococcus aureus β-lactamase
Rizwi, I., Tan, A. K., Fink, A. L., & Virden, R. (1989) · Biochemical Journal · doi:10.1042/bj2580205 · Cited by 22
Itoh, S., & Navia, M. A. (1995) · Protein Science · doi:10.1002/pro.5560041103 · Cited by 22
Conformationally constrained HIV-1 protease inhibitors
Vacca, J. P., Fitzgerald, P. M. D., Holloway, M. K., et al. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(94)80025-1 · Cited by 22
Mitchell, A. (1996) · Nature · doi:10.1038/384026a0 · Cited by 22
Petros, A. M., Luly, J. R., Liang, H., & Fesik, S. W. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00075a007 · Cited by 22
Green, B. G., Chabin, R. M., Mills, S., et al. (1995) · Biochemistry · doi:10.1021/bi00044a010 · Cited by 21
Nonpeptide HIV protease inhibitors designed to replace a bound water
Chenera, B., DesJarlais, R. L., Finkelstein, J. A., et al. (1993) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80749-6 · Cited by 18
Prorok, M., Albeck, A., Foxman, B. M., et al. (1994) · Biochemistry · doi:10.1021/bi00198a050 · Cited by 16
Asymmetric synthesis of cis- and trans-γ-lactones useful in HIV-1 protease inhibitor synthesis
Trova, M. P., Wissner, A., Casscles, W. T., & Hsu, G. C. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80260-2 · Cited by 13
Robinson, V. J., Pauls, H. W., Coles, P. J., et al. (1992) · Bioorganic Chemistry · doi:10.1016/0045-2068(92)90024-w · Cited by 13
Synthesis and structure-activity relationships of macrocyclic FKBP ligands
Luengo, J. I., Konialian-Beck, A. L., Levy, M. A., Brandt, M. A., Eggleston, D. S., & Holt, D. A. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80136-0 · Cited by 13
Synthesis and biological evaluation of a series of HIV-1 protease inhibitors
Trova, M. P., Babine, R. E., Byrn, R. A., Casscles, W. T., Hastings, R. C., Hsu, G. C., Jirousek, M. R., Johnson, B. D., Kerwar, S. S., Schow, S. R., et al. (1993) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)80024-4 · Cited by 11
Self-citationBabine, R. E., Bleckman, T. M., Littlefield, E. S., Parge, H. E., Pelletier, L. A., Lewis, C. T., FRENCH, J. V., Imbacuan, M., Katoh, S., Tatlock, J. H., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00032-7 · Cited by 11
Self-citationThe affinity of the excised binding domain of FK-506 for the immunophilin FKBP12.
Teague, S. J., & Stocks, M. J. (1993) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80992-6 · Cited by 10
Tatlock, J. H., Kalish, V. J., Parge, H. E., Knighton, D. R., Showalter, R. E., Lewis, C. T., FRENCH, J. V., & Villafranca, J. E. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00429-w · Cited by 10
Cited by
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fleming, F. F., Yao, L., Ravikumar, P. C., Funk, L., & Shook, B. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100762r · Cited by 1,754
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Synthetic Analogues Relevant to the Structure and Function of Zinc Enzymes
Parkin, G. (2004) · Chemical Reviews · doi:10.1021/cr0206263 · Cited by 931
Metadata
- Authors
- Babine, R. E., & Bender, S. L.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-08-01
- Volume
- 97
- Issue
- 5
- Pages
- 1359-1472
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2091379422
- Cited by
- 892
- References
- 250
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.